Healthcare - Biotechnology - NASDAQ - US
$ 1.99
-4.78 %
$ 180 M
Market Cap
-1.2
P/E
INCOME STATEMENT
34.5 M
REVENUE
-116 M
OPERATING INCOME
-102 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Caribou Biosciences, Inc.
| Revenue | 34.5 M |
| Cost Of Revenue | 112 M |
| Gross Profit | -77.6 M |
| Operating Expenses | 151 M |
| Operating Income | -116 M |
| Other Expenses | -14 M |
| Net Income | -102 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 34.5 | 13.9 | 9.6 | 12.4 | 5.8 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 112.1 | 3.6 | 1.0 | 34.4 | 23.6 |
| Gross Profit | (77.6) | 10.2 | 8.6 | (22.1) | (17.8) |
| OPERATING INCOME | |||||
| Operating Expenses | 150.5 | 120.2 | 76.6 | 48.5 | 40.1 |
| Selling, General and Administrative Expenses | 38.5 | 38.0 | 24.3 | 14.1 | 16.5 |
| Research and Development Expenses | 112.1 | 82.2 | 52.3 | 34.4 | 23.6 |
| Operating Income | (116.1) | (106.4) | (67.0) | (36.1) | (34.3) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0 | 8 K | 20 K | 4 K |
| Total Other Income | 14.2 | 7.0 | 0.4 | 3 K | 3.3 |
| Pre-Tax Income | (101.9) | (99.4) | (66.6) | (36.1) | (31.0) |
| NET INCOME | |||||
| Tax Provision | 0.2 | 70 K | 0.3 | (1.8) | (7.5) |
| Net Income | (102.1) | (99.4) | (66.9) | (34.3) | (23.4) |
| EPS | 1.38 | 1.64 | 1.11 | 0.57 | 0.39 |